 |
Articles: Clinical Pharmacology |
Prior Articles
Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease
Expert Opinion on Investigational Drugs, 09/21/09
Current opinion: Pharmacological approaches in asthma and COPD
Breathe, 09/18/09 Efficacy and Safety of Low Dose rt-PA for the Treatment of Acute Pulmonary Thromboembolism: A Randomized, Multi-Center, Controlled Trial
Chest, 09/18/09 Adding Omalizumab to the Therapy of Adolescents With Persistent Uncontrolled Moderate-Severe Allergic Asthma
Clinical Pediatrics, 09/18/09
Exclusive Author Commentary A randomized, comparative study of formoterol and terbutaline dry powder inhalers in the treatment of mild to moderate asthma exacerbations in the pediatric acute care setting
Annals of Allergy, Asthma, and Immunology, 09/18/09 Safety of Binodenoson, a Selective Adenosine A2A Receptor Agonist Vasodilator Pharmacologic Stress Agent, in Healthy Subjects with Mild, Intermittent Asthma
Circulation: Cardiovascular Imaging, 09/18/09 Fixed-dose combination of cefepime plus amikacin (POTENTOX) inhibits pneumonia infection
Experimental Lung Research, 09/18/09 Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease
Trends in Pharmacological Sciences, 09/18/09 Sepsis, Mechanical Ventilation, Occupational and Environmental Lung Disease, and Sleep
Proceedings of the American Thoracic Society, 09/17/09
Free full text
Pharmacokinetics and safety of tobramycin administered by the PARI eFlow rapid nebulizer in cystic fibrosis
Journal of Cystic Fibrosis, 09/15/09 Magnesium for treatment of asthma in children
Canadian Family Physician, 09/15/09
Free full text
Coagulation factors in the airways in moderate and severe asthma and the effect of inhaled steroids
Thorax, 09/15/09 Effectiveness of Oral Rinse with Chlorhexidine in Preventing Nosocomial Respiratory Tract Infections among Intensive Care Unit Patients
Infection Control and Hospital Epidemiology, 09/15/09 Is capecitabine a new choice of treatment for lung adenocarcinoma? A case report involving partial response in second line of treatment and hypothesis of the biological basis
Clinical and Translational Oncology, 09/15/09 Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol
Journal of Rheumatology, 09/14/09 Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma
Respiratory Medicine, 09/14/09 Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases
Journal of Clinical Oncology, 09/11/09 Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer
Journal of Clinical Oncology, 09/11/09 Gemcitabine plus cisplatin chemotherapy with concurrent para-toluenesulfonamide local injection therapy for peripherally advanced nonsmall cell lung cancer larger than 3 cm in the greatest dimension
Anti-Cancer Drugs, 09/11/09 Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non–small-cell lung cancer
Journal of Clinical Oncology, 09/10/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Chest, Thorax, American Journal of Respiratory and Critical Care Medicine
more...
|
250 Available Pages
|
|
